Skip to main content

Table 5 Baseline population characteristics by genetic variants of the CD36 gene in each group

From: Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females

Variables

Control

Type 2 Diabetes Mellitus

GG

AA/AG

p value

GG

AA/AG

p value

rs1761667

      

Waist size (cm)

84.00 ± 10.19

83.54 ± 9.20

0.87

82.32 ± 7.67

86.16 ± 7.30

0.94

Waist–hip ratio

0.82 ± 0.10

0.83 ± 0.07

0.51

0.88 ± 0.07

0.89 ± 0.06

0.64

Body mass index (kg/m2)

24.58 ± 2.38

23.95 ± 3.07

0.42

24.30 ± 1.97

24.66 ± 2.50

0.57

Glycated hemoglobin (%)

5.08 ± 0.57

4.93 ± 0.39

0.28

9.35 ± 2.16

9.29 ± 2.42

0.93

IR-HOMA

4.04 ± 1.64

3.57 ± 1.70

0.34

14.04 ± 10.49

9.40 ± 4.55

0.21

Total cholesterol (g/l)

2.32 ± 0.42

2.04 ± 0.45

0.13

2.28 ± 0.42

2.29 ± 0.58

0.93

HDL cholesterol (g/l)

0.63 ± 0.13

0.61 ± 0.15

0.48

0.59 ± 0.17

0.54 ± 0.18

0.38

LDL cholesterol (g/l)

1.46 ± 0.30

1.34 ± 0.41

0.26

1.62 ± 0.47

1.69 ± 0.59

0.63

Triglycerides (g/l)

0.84 ± 0.35

0.76 ± 0.28

0.34

0.95 ± 0.63

0.92 ± 0.47

0.88

 

CC

AA/AC

p value

CC

AA/AC

p value

rs3211867

      

Waist size (cm)

80.95 ± 9.23

85.48 ± 9.54

0.10

86.90 ± 7.34

85.80 ± 7.55

0.61

Waist–hip ratio

0.80 ± 0.07

0.84 ± 0.09

0.10

0.90 ± 0.08

0.87 ± 0.06

0.25

Body mass index (kg/m2)

23.46 ± 2.87

24.74 ± 2.60

0.12

24.46 ± 2.34

24.49 ± 2.20

0.97

Glycated hemoglobin (%)

4.86 ± 0.44

5.09 ± 0.50

0.09

9.77 ± 2.53

9.02 ± 2.07

0.28

IR-HOMA

4.01 ± 1.87

3.67 ± 1.57

0.51

6.41 ± 7.88

9.06 ± 5.02

0.14

Total cholesterol (g/l)

2.11 ± 0.48

2.15 ± 0.43

0.78

2.33 ± 0.60

2.25 ± 0.42

0.65

HDL cholesterol (g/l)

0.59 ± 0.15

0.64 ± 0.13

0.26

0.55 ± 0.13

0.57 ± 0.20

0.61

LDL cholesterol (g/l)

1.45 ± 0.37

1.37 ± 0.37

0.48

1.72 ± 0.66

1.61 ± 0.43

0.49

Triglycerides (g/l)

0.73 ± 0.25

0.84 ± 0.34

0.18

1.07 ± 0.68

0.85 ± 0.44

0.22

  1. HOMA-IR Homeostasis Model Assessment-Insulin Resistance